Share this post on:

Product Name :
Thymopetidum

Search keywords :
Thymopentin

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
Undisclosed

First Approval Country :
Mainland China

First Approval Date Filter:
2000

Origin Company_Name :
Sichuan Kelun Pharmaceutical Co Ltd

Active Company_Name :
Hunan Kelun Pharmaceutical Co Ltd

Active Indication_Name:
Immunologic Deficiency Syndromes

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JNK2 Rabbit mAb web
CD90/Thy-1 Antibody manufacturer
Phospho-ERK1/2 (Thr202/Thr185) Antibody: Phospho-ERK1/2 (Thr202/Thr185) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44,42 kDa, targeting to Phospho-ERK1/2 (Thr202/Thr185). It can be used for WB,IP assays with tag free, in the background of Human, Hamster, Rat.

Share this post on:

Author: Interleukin Related